L3VLUP
ProSign in

TXG in the 13F filings

10X Genomics Inc · CUSIP 88025U109

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2025
the date the book describes
Filed
15 Aug 2025
latest of these filings; the earliest 30 Jul 2025
Managers listing it
8
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q1 2025 and Q2 2025; 7 listed it in both
Shares listed
19,975,097
combined, among listed positions
Reported value
$231m
combined, at the quarter end

Among the 95 comparable managers: 3 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing TXG in Q2 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

8 of 8 holders

ActionFiling
ARK Investment Management LLC13,892,103$161m1.18%Added+1,046,39030 Jul 2025 (the filing on sec.gov)
Two Sigma Advisers LP1,814,600$21munder 0.1%Added+69,80014 Aug 2025 (the filing on sec.gov)
Voloridge Investment Management LLC1,526,892$18m0.07%Trimmed-96,78314 Aug 2025 (the filing on sec.gov)
Capital World Investors1,452,300$17munder 0.1%Held013 Aug 2025 (the filing on sec.gov)
Acadian Asset Management LLC623,138$7.2munder 0.1%Addedn.a.7 Aug 2025 (the filing on sec.gov)
PDT Partners LLC499,890$5.8m0.33%Trimmed-159,15014 Aug 2025 (the filing on sec.gov)
Caxton Associates LLP87,406$1.0munder 0.1%Trimmed-259,38815 Aug 2025 (the filing on sec.gov)
Moore Capital Management LP78,768$912kunder 0.1%Trimmed-131,46214 Aug 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2025 to Q2 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
7 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

051015202020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
TXG by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20193$12mn.a.n.a.
Q4 20192$86mn.a.n.a.
Q1 20205$118mn.a.n.a.
Q2 20207$931mn.a.n.a.
Q3 202017$1.8bnn.a.n.a.
Q4 202014$1.9bnn.a.n.a.
Q1 202110$3.0bnn.a.n.a.
Q2 20218$3.7bnn.a.n.a.
Q3 20217$2.6bnn.a.n.a.
Q4 20217$2.9bnn.a.n.a.
Q1 20225$849mn.a.n.a.
Q2 20225$642mn.a.n.a.
Q3 20225$425mn.a.n.a.
Q4 20226$546mn.a.n.a.
Q1 202310$995mn.a.n.a.
Q2 202311$1.4bnn.a.n.a.
Q3 202312$1.3bnn.a.n.a.
Q4 20239$1.7bn54
Q1 202410$1.2bn72
Q2 20246$289m41
Q3 20247$337m33
Q4 20246$247m51
Q1 20257$165m70
Q2 20258$231m34
Q3 20256$187m05
Q4 20255$272m1617
Q1 20262$259m1120
Q2 20265$1.2bn1516

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

TXG and LLY →TXG and JNJ →TXG and VRTX →Choose a stock to compare with TXG →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own TXG, latest filings →Back to the 13F Explorer →